{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:16:24Z","timestamp":1784546184863,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:00:00Z","timestamp":1589587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B03029340"],"award-info":[{"award-number":["NRF-2017R1D1A1B03029340"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemokines interact with hepatic resident cells during inflammation and fibrosis. CC chemokine ligand (CCL) 20 has been reported to be important in inflammation and fibrosis in the liver. We hypothesized that visfatin, an adipocytokine, could play a role in hepatic fibrosis via CCL20. We investigated the effect of visfatin on CCL20 in THP-1 human promonocytic cells and examined the molecular mechanisms involved. Following treatment of THP-1 cells with visfatin, CCL20 expression and secretion were assessed. We assessed the intracellular signaling molecules IKK\/NF-\u03baB, JAK2\/STAT3, MAPKs, and MKK3\/6 by western blotting. We treated THP-1 cells with visfatin and signaling inhibitors, and examined CCL20 mRNA and protein levels. To investigate the effect of visfatin-induced CCL20 expression in hepatic stellate cells (HSCs), LX-2 cells were co-cultured with the culture supernatant of THP-1 cells with or without anti-CCL20 neutralizing antibodies, and fibrosis markers were examined by RT-PCR and immunoblotting. In THP-1 cells, visfatin increased the CCL20 mRNA and protein levels. visfatin increased the activities of the NF-\u03baB, p38, and MLK3\/6 signaling pathways but not those of the JAK2\/STAT3 and ERK pathways. Visfatin treatment together with an NF-\u03baB, p38, or MLK3 inhibitor reduced the mRNA and protein levels of CCL20. The visfatin-induced CCL20 increased the expression of fibrosis markers and CCR6 in HSCs. Following neutralization of CCL20, the levels of fibrosis markers and CCR6 were decreased. Visfatin increases the expression of CCL20 via the NF-\u03baB and MKK3\/6-p38 signaling pathways in macrophages, and visfatin-induced CCL20 expression promotes the fibrosis markers in HSCs.\n<\/jats:p>","DOI":"10.1007\/s11033-020-05510-7","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T05:02:37Z","timestamp":1589605357000},"page":"4285-4293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["CCL20 induced by visfatin in macrophages via the NF-\u03baB and MKK3\/6-p38 signaling pathways contributes to hepatic stellate cell activation"],"prefix":"10.1007","volume":"47","author":[{"given":"Yu Jung","family":"Heo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-E","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Young","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Jin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yup","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8958-7164","authenticated-orcid":false,"given":"Hae Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,16]]},"reference":[{"key":"5510_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, St Sauver J et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113\u2013121","journal-title":"Gastroenterology"},{"key":"5510_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214:199\u2013210","journal-title":"J Pathol"},{"key":"5510_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","volume":"14","author":"NL Gluchowski","year":"2017","unstructured":"Gluchowski NL, Becuwe M, Walther TC et al (2017) Lipid droplets and liver disease: from basic biology to clinical implications. Nat Rev Gastroenterol Hepatol 14:343\u2013355","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5510_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F (2014) Roles for chemokines in liver disease. Gastroenterology 147:577\u2013594.e1","journal-title":"Gastroenterology"},{"key":"5510_CR5","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"338","author":"AD Luster","year":"1998","unstructured":"Luster AD (1998) Chemokines\u2013chemotactic cytokines that mediate inflammation. N Engl J Med 338:436\u2013445","journal-title":"N Engl J Med"},{"key":"5510_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0030-1255351","volume":"30","author":"HE Wasmuth","year":"2010","unstructured":"Wasmuth HE, Tacke F, Trautwein C (2010) Chemokines in liver inflammation and fibrosis. Semin Liver Dis 30:215\u2013225","journal-title":"Semin Liver Dis"},{"key":"5510_CR7","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1074\/jbc.272.9.5846","volume":"272","author":"K Hieshima","year":"1997","unstructured":"Hieshima K, Imai T, Opdenakker G et al (1997) Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 272:5846\u20135853","journal-title":"J Biol Chem"},{"key":"5510_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","volume":"14","author":"E Schutyser","year":"2003","unstructured":"Schutyser E, Struyf S, Van Damme J (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14:409\u2013426","journal-title":"Cytokine Growth Factor Rev"},{"key":"5510_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12967-018-1490-y","volume":"16","author":"X Chu","year":"2018","unstructured":"Chu X, Jin Q, Chen H, Wood GC et al (2018) CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. J Transl Med 16:108","journal-title":"J Transl Med"},{"key":"5510_CR10","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1136\/gutjnl-2013-306098","volume":"63","author":"S Affo","year":"2014","unstructured":"Affo S, Morales-Ibanez O, Rodrigo-Torres D et al (2014) CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis. Gut 63:1782\u20131792","journal-title":"Gut"},{"key":"5510_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/abbs\/gmt049","volume":"45","author":"Q Li","year":"2013","unstructured":"Li Q, Laumonnier Y, Syrovets T et al (2013) Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages. Acta Biochim Biophys Sin (Shanghai) 45:593\u2013600","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"5510_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/jcb.20672","volume":"97","author":"S Brand","year":"2006","unstructured":"Brand S, Olszak T, Beigel F et al (2006) Cell differentiation dependent expressed CCR6 mediates ERK-1\/2, SAPK\/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 97:709\u2013723","journal-title":"J Cell Biochem"},{"key":"5510_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/cancers8050051","volume":"8","author":"C Rattanasinchai","year":"2016","unstructured":"Rattanasinchai C, Gallo KA (2016) MLK3 signaling in cancer invasion. Cancers (Basel) 8:51","journal-title":"Cancers (Basel)"},{"key":"5510_CR14","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1002\/jcb.25973","volume":"118","author":"K Tomita","year":"2017","unstructured":"Tomita K, Kabashima A, Freeman BL et al (2017) Mixed lineage kinase 3 mediates the induction of CXCL10 by a STAT1-dependent mechanism during hepatocyte lipotoxicity. J Cell Biochem 118:3249\u20133259","journal-title":"J Cell Biochem"},{"key":"5510_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00441-014-1997-3","volume":"359","author":"K Xiao","year":"2015","unstructured":"Xiao K, Zou WH, Yang Z et al (2015) The role of visfatin on the regulation of inflammation and apoptosis in the spleen of LPS-treated rats. Cell Tissue Res 359:605\u2013618","journal-title":"Cell Tissue Res"},{"key":"5510_CR16","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","volume":"178","author":"AR Moschen","year":"2017","unstructured":"Moschen AR, Kaser A, Enrich B et al (2017) Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178:1748\u20131758","journal-title":"J Immunol"},{"key":"5510_CR17","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.33594\/000000098","volume":"52","author":"YT Lin","year":"2019","unstructured":"Lin YT, Chen LK, Jian DY et al (2019) Visfatin promotes monocyte adhesion by upregulating ICAM-1 and VCAM-1 expression in endothelial cells via activation of p38-PI3K-Akt signaling and subsequent ROS production and IKK\/NF-kappaB activation. Cell Physiol Biochem 52:1398\u20131411","journal-title":"Cell Physiol Biochem"},{"key":"5510_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cellsig.2013.12.010","volume":"26","author":"MR Yun","year":"2014","unstructured":"Yun MR, Seo JM, Park HY (2014) Visfatin contributes to the differentiation of monocytes into macrophages through the differential regulation of inflammatory cytokines in THP-1 cells. Cell Signal 26:705\u2013715","journal-title":"Cell Signal"},{"key":"5510_CR19","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3390\/ijms18071392","volume":"18","author":"C Buechler","year":"2017","unstructured":"Buechler C, Haberl EM, Rein-Fischboeck L et al (2017) Adipokines in liver cirrhosis. Int J Mol Sci 18:1392","journal-title":"Int J Mol Sci"},{"key":"5510_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cyto.2018.11.013","volume":"117","author":"E Neumann","year":"2019","unstructured":"Neumann E, Lepper N, Vasile M et al (2019) Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement. Cytokine 117:41\u201349","journal-title":"Cytokine"},{"key":"5510_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1055\/s-0030-1249059","volume":"42","author":"XY Yu","year":"2010","unstructured":"Yu XY, Qiao SB, Guan HS et al (2010) Effects of visfatin on proliferation and collagen synthesis in rat cardiac fibroblasts. Horm Metab Res 42:507\u2013513","journal-title":"Horm Metab Res"},{"key":"5510_CR22","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1016\/j.bbagen.2016.08.019","volume":"1861","author":"P Dutta","year":"2017","unstructured":"Dutta P, Ta A, Thakur BK, Dasgupta N et al (2017) Biphasic Ccl20 regulation by Toll-like receptor 9 through the activation of ERK-AP-1 and non-canonical NF-kappaB signaling pathways. Biochim Biophys Acta Gen Subj 1861:3365\u20133377","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"5510_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/exd.13750","volume":"27","author":"HC Bae","year":"2018","unstructured":"Bae HC, Jeong SH, Kim JH et al (2018) RIP4 upregulates CCL20 expression through STAT3 signalling in cultured keratinocytes. Exp Dermatol 27:1126\u20131133","journal-title":"Exp Dermatol"},{"key":"5510_CR24","doi-asserted-by":"publisher","first-page":"e2005869","DOI":"10.1371\/journal.pbio.2005869","volume":"16","author":"W Chen","year":"2018","unstructured":"Chen W, Qin Y, Wang D et al (2018) CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biol 16:e2005869","journal-title":"PLoS Biol"},{"key":"5510_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F (2017) Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol 17:306\u2013321","journal-title":"Nat Rev Immunol"},{"key":"5510_CR26","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","volume":"58","author":"JP Pradere","year":"2013","unstructured":"Pradere JP, Kluwe J, De Minicis S et al (2013) Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 58:1461\u20131473","journal-title":"Hepatology"},{"key":"5510_CR27","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","volume":"67","author":"CR Gandhi","year":"2017","unstructured":"Gandhi CR (2017) Hepatic stellate cell activation and pro-fibrogenic signals. J Hepatol 67:1104\u20131105","journal-title":"J Hepatol"},{"key":"5510_CR28","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/intimm\/13.10.1255","volume":"13","author":"S Fujiie","year":"2001","unstructured":"Fujiie S, Hieshima K, Izawa D et al (2001) Proinflammatory cytokines induce liver and activation-regulated chemokine\/macrophage inflammatory protein-3alpha\/CCL20 in mucosal epithelial cells through NF-kappaB. Int Immunol 13:1255\u20131263","journal-title":"Int Immunol"},{"key":"5510_CR29","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1182\/blood-2003-01-0007","volume":"102","author":"A Meissner","year":"2003","unstructured":"Meissner A, Zilles O, Varona R et al (2003) CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. Blood 102:2724\u20132727","journal-title":"Blood"},{"key":"5510_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1128\/IAI.71.1.365-373.2003","volume":"71","author":"TJ Lin","year":"2003","unstructured":"Lin TJ, Maher LH, Gomi K et al (2003) Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa. Infect Immun 71:365\u2013373","journal-title":"Infect Immun"},{"key":"5510_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/dmrr.1201","volume":"27","author":"YH Chang","year":"2011","unstructured":"Chang YH, Chang DM, Lin KC et al (2011) Visfatin in overweight\/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 27:515\u2013527","journal-title":"Diabetes Metab Res Rev"},{"key":"5510_CR32","doi-asserted-by":"publisher","first-page":"4021623","DOI":"10.1155\/2019\/4021623","volume":"2019","author":"YJ Heo","year":"2019","unstructured":"Heo YJ, Choi SE, Jeon JY et al (2019) Visfatin induces inflammation and insulin resistance via the NF-kappaB and STAT3 signaling pathways in hepatocytes. J Diabetes Res 2019:4021623","journal-title":"J Diabetes Res"},{"key":"5510_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-2265.2007.02966.x","volume":"67","author":"K Oki","year":"2007","unstructured":"Oki K, Yamane K, Kamei N et al (2007) Circulating visfatin level is correlated with inflammation, but not with insulin resistance. Clin Endocrinol (Oxf) 67:796\u2013800","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5510_CR34","first-page":"28","volume":"31","author":"Z Mousavi","year":"2017","unstructured":"Mousavi Z, Ganji A, Farrokh Tehrani D et al (2017) Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome. Med J Islam Repub Iran 31:28","journal-title":"Med J Islam Repub Iran"},{"key":"5510_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.clinbiochem.2012.11.006","volume":"46","author":"T Auguet","year":"2013","unstructured":"Auguet T, Terra X, Porras JA et al (2013) Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease. Clin Biochem 46:202\u2013208","journal-title":"Clin Biochem"},{"key":"5510_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4172\/2469-9756.1000131","volume":"4","author":"M Ozgocmen","year":"2018","unstructured":"Ozgocmen M, Gokcimen A, Oncu M et al (2018) Effects of non-alcoholic fatty liver disease on visfatin and IL-6 levels in mice: an immunohistochemical study. Immunochem Immunopathol 4:131","journal-title":"Immunochem Immunopathol"},{"key":"5510_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/glia.10193","volume":"41","author":"E Ambrosini","year":"2003","unstructured":"Ambrosini E, Columba-Cabezas S, Serafini B et al (2003) Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha\/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41:290\u2013300","journal-title":"Glia"},{"key":"5510_CR38","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.bbrc.2004.07.207","volume":"322","author":"H Fujii","year":"2004","unstructured":"Fujii H, Itoh Y, Yamaguchi K et al (2004) Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44\/42 MAPK in vitro. Biochem Biophys Res Commun 322:1052\u20131058","journal-title":"Biochem Biophys Res Commun"},{"key":"5510_CR39","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1210\/en.2010-1481","volume":"152","author":"N Kanda","year":"2011","unstructured":"Kanda N, Hau CS, Tada Y et al (2011) Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. Endocrinology 152:3155\u20133164","journal-title":"Endocrinology"},{"key":"5510_CR40","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/jcmm.12781","volume":"20","author":"B Wang","year":"2016","unstructured":"Wang B, Shi L, Sun X et al (2016) Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway. J Cell Mol Med 20:920\u2013929","journal-title":"J Cell Mol Med"},{"key":"5510_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9\u201318","journal-title":"Cell Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05510-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T23:44:37Z","timestamp":1621122277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05510-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,16]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["5510"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05510-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,16]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not involve human Participants or Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}